Enara group Congo Republic

Advancing cancer immunotherapy by targeting the

Latest News. 3rd October 2024 Enara Bio raises $32.5 million Series B financing to advance first-in-class pipeline of TCR-based immunotherapies targeting novel Dark Antigens® New investors Pfizer Ventures and M Ventures co-led the

Kinshasa, Democratic Republic of Congo (DRC)

Kinshasa, Democratic Republic of Congo (DRC) Office Complex Design & Construction Keta designed, built, and constructed for the Department of State (DOS) a 16-unit modular office complex in Kinshasa, DRC. Contact Keta

Power Your Home With Clean Solar Energy?

We are a premier solar development, engineering, procurement and construction firm.